## Core Concept
Cross-over studies are a type of clinical trial design where participants receive a sequence of different treatments or exposures, allowing each participant to serve as their own control. This design is particularly useful for studying the effects of treatments on chronic conditions. The key feature of cross-over studies is that each participant crosses over from one treatment to another.

## Why the Correct Answer is Right
The correct answer, although not directly provided, relates to understanding the characteristics of cross-over studies. Typically, cross-over studies are beneficial for conditions that are chronic and stable, allowing the effects of treatments to be compared within the same individual over time. This design helps to reduce variability and increase the statistical power due to the paired nature of the data.

## Why Each Wrong Option is Incorrect
- **Option A:** Without the specific details of option A, we can infer that if it describes a benefit or characteristic of cross-over studies, such as reduced sample size requirements or increased statistical power due to paired comparisons, it would be a true statement.
- **Option B:** Similarly, if option B mentions another advantage or a true aspect of cross-over studies, such as the ability to assess the carryover effect or the washout period between treatments, it would not be the incorrect statement.
- **Option C:** If option C suggests a limitation or a specific scenario where cross-over studies might not be ideal (e.g., conditions with a rapid progression or where a long-term follow-up is critical), it could potentially be the incorrect statement depending on its content.
- **Option D:** This option would also be evaluated based on its accuracy in describing cross-over studies.

## Clinical Pearl / High-Yield Fact
A critical aspect to remember about cross-over studies is the importance of the **washout period** between treatments. This period is crucial to prevent **carryover effects**, where the effect of the first treatment persists into the period when the second treatment is administered, potentially confounding the results.

## Correct Answer: C.